FDA approves once-monthly Abilify for schizophrenia
February 28, 2013 at 19:21 PM EST
Feb 28 (Reuters) - U.S. regulators on Thursday approved a once-monthly injectable form of Abilify, the blockbuster treatment for schizophrenia, which will be sold by Japanese drugmaker Otsuka and Danish drug group Lundbeck .
